Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles

被引:533
作者
Bilati, U [1 ]
Allémann, E [1 ]
Doelker, E [1 ]
机构
[1] Univ Geneva, Sch Pharm, CH-1211 Geneva 4, Switzerland
关键词
entrapment efficiency; nanoparticles; nanoprecipitation; protein; PLA; PLGA;
D O I
10.1016/j.ejps.2004.09.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study investigates formulation and process modifications to improve the versatility of the nanoprecipitation technique, particularly with respect to the encapsulation of hydrophilic drugs (e.g. proteins). More specifically, the principal objective was to explore the influence of such modifications on nanoparticle size. Selected parameters of the nanoprecipitation method, such as the solvent and the non-solvent nature, the solvent/non-solvent volume ratio and the polymer concentration, were varied so as to obtain polymeric nano-carriers. The feasibility of such a modified method was assessed and resulting unloaded nanoparticles were characterized with respect to their size and shape. It was shown that the mean particle size was closely dependent on the type of non-solvent selected. When alcohols were used, the final mean size increased in the sequence: methanol < ethanol < propanol. Surfactants added to the dispersing medium were usually unnecessary for final suspension stabilization. Changing the solvent/non-solvent volume ratio was also not a determinant factor for nanoparticle formation and their final characteristics, provided that the final mixture itself did not become a solvent for the polymer. A too high polymer concentration in the solvent, however, prevented nanoparticle formation. Both poly(lactic acid) (PLA) and poly(D,L-lactic-co-glycolic acid) (PLGA) could be used by accurately choosing the polymer solvent and in this respect, some non-toxic solvents with different dielectric constants were selected. The nanoparticles obtained ranged from about 85-560 nm in size. The nanoparticle recovery step however needs further improvements, since bridges between particles which cause flocculation Could be observed. Finally, the presented results demonstrate that the nanoprecipitation technique is more versatile and flexible than previously thought and that a wide range of parameters can be modified. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:67 / 75
页数:9
相关论文
共 18 条
  • [1] [Anonymous], [No title captured], Patent No. [593,522, 593522]
  • [2] Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method
    Barichello, JM
    Morishita, M
    Takayama, K
    Nagai, T
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (04) : 471 - 476
  • [3] BRENNAN TV, 1993, PROTEIN SCI, V2, P331
  • [4] COMMUNICATION TO THE EDITOR ON PROTEIN SOLUBILITY IN ORGANIC-SOLVENTS
    CHIN, JT
    WHEELER, SL
    KLIBANOV, AM
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 1994, 44 (01) : 140 - 145
  • [5] Thermodynamic parameters on poly(D,L-lactide-co-glycolide) particle size in emulsification-diffusion process
    Choi, SW
    Kwon, HY
    Kim, WS
    Kim, JH
    [J]. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2002, 201 (1-3) : 283 - 289
  • [6] APPLICATION OF AN ORIGINAL PROCESS FOR OBTAINING COLLOIDAL DISPERSIONS OF SOME COATING POLYMERS - PREPARATION, CHARACTERIZATION, INDUSTRIAL SCALE-UP
    DELABOURET, A
    THIOUNE, O
    FESSI, H
    DEVISSAGUET, JP
    PUISIEUX, F
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (02) : 229 - 241
  • [7] NANOCAPSULE FORMATION BY INTERFACIAL POLYMER DEPOSITION FOLLOWING SOLVENT DISPLACEMENT
    FESSI, H
    PUISIEUX, F
    DEVISSAGUET, JP
    AMMOURY, N
    BENITA, S
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 55 (01) : R1 - R4
  • [8] PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug
    Govender, T
    Stolnik, S
    Garnett, MC
    Illum, L
    Davis, SS
    [J]. JOURNAL OF CONTROLLED RELEASE, 1999, 57 (02) : 171 - 185
  • [9] Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers
    Quintanar-Guerrero, D
    Allémann, E
    Fessi, H
    Doelker, E
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1998, 24 (12) : 1113 - 1128
  • [10] SIEMANN U, 1985, P INT S CONTROLLED R, V12, P53